Evidence map›Paper›PMID 42089967›Full record

ArticleEuropean radiology2026

Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy.

Hardeep Singh Kalsi, Kristofer Linton-Reid, Changhyun Kim, Mitchell Chen, Victoria Crowe, Esubalew Alemu, Samir Mahboobani, David Gibeon, Alexander Procter, Mohsen Hajhosseiny and 10 more

Abstract readMulticenter Study
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Hardeep Singh KalsiEarly Diagnosis and Detection Centre, Royal Marsden Hospital and Institute for Cancer Research Biomedical Research Centre, London, UK. h.kalsi@nhs.net.ORCID http://orcid.org/0000-0002-5722-0034
Kristofer Linton-ReidDepartment of Surgery and Cancer, Imperial College London, London, UK.
Changhyun KimInstitute for Cancer Research, London, UK.
Mitchell ChenDepartment of Surgery and Cancer, Imperial College London, London, UK.
Victoria CroweDepartment of Radiology, Royal Marsden Hospital NHS Foundation Trust, London, UK.
Esubalew AlemuDepartment of Radiology, Imperial College Healthcare NHS Trust, London, UK.
Samir MahboobaniDepartment of Radiology, Imperial College Healthcare NHS Trust, London, UK.
David GibeonDepartment of Radiology, University College London Hospitals, London, UK.
Alexander ProcterDepartment of Radiology, University College London Hospitals, London, UK.
Mohsen HajhosseinyDepartment of Radiology, Imperial College Healthcare NHS Trust, London, UK.
Cara OwensDepartment of Radiology, Royal Marsden Hospital NHS Foundation Trust, London, UK.
Emily C BartlettNational Heart and Lung Institute, Imperial College London, London, UK.
Nuria PortaInstitute for Cancer Research, London, UK.
Thesha ThavarajaInstitute for Cancer Research, London, UK.
Simon DoranInstitute for Cancer Research, London, UK.
Anand DevarajNational Heart and Lung Institute, Imperial College London, London, UK.
Bhupinder SharmaDepartment of Radiology, Royal Marsden Hospital NHS Foundation Trust, London, UK.
Arjun NairDepartment of Radiology, University College London Hospitals, London, UK.
Eric O AboagyeDepartment of Surgery and Cancer, Imperial College London, London, UK.
Richard W LeeEarly Diagnosis and Detection Centre, Royal Marsden Hospital and Institute for Cancer Research Biomedical Research Centre, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesNew pulmonary lesions after prior cancer present a diagnostic challenge, potentially representing malignancy relapse or new primary lung cancer due to shared risk factors and/or impact of prior oncological therapies. This study evaluated radiologist-defined semantic features for differentiation of second primary lung cancer (SPLC) versus lung metastasis (LM). MATERIALS AND

methods651 single-timepoint, pre-treatment CT thorax scans from the multicentre retrospective AI-SONAR biomarker study (IRAS 331656 REC 23/NE/0151) were divided for review by nine thoracic oncology radiologists to evaluate eight semantic features. Logistic regression analysis was undertaken to identify significant features and a developed 'Second Malignancy Aetiology Recognition Tool' model (SMART) was compared to real-world clinical reader performance using McNemar's test.

results649 scans were technically usable, 299 SPLC and 350 LM. Emphysema (p < 0.0001, OR 0.20 [95% CI 0.14-0.29]), irregular contour (p < 0.0001, OR 0.31 [95% CI 0.20-0.48]) and spiculation (p = 0.013, OR 0.51 [95% CI 0.30-0.89]) were more prevalent in SPLC (OR < 1 indicates association with SPLC). Peripheral lung distribution (p = 0.003, OR 1.80 [95% CI 1.20-2.68]) was more common in LM (OR > 1 indicates metastasis). SMART model AUC was 0.81 (95% CI 0.78-0.84), LM classification accuracy 75% vs 69% by radiology reader and McNemar p-value < 0.01 for comparative accuracy. 550/649 cases were predicted SPLC or LM by radiologists, in which the SMART model LM classification accuracy was 74% vs 77% by reader and McNemar p-value 0.20.

conclusionIn new lesions after prior treated cancer, radiologist readers called SPLC more often than LM. The SMART model performed comparably with expert thoracic radiologists in the diagnosis of LM. KEY POINTS: Question Differentiating the malignant aetiology of indeterminate lung lesions after prior cancer presents a growing diagnostic challenge. The literature and nodule guidelines are sparse for this setting. Findings A SMART model derived from semantic CT imaging features correctly classified malignant lung lesions as metastasis or lung cancer, more often than thoracic radiologists. Clinical relevance The SMART model could improve the stratification of malignant new lung lesions after prior cancer. This may lead to earlier diagnosis and optimise patient management, treatment selection and downstream outcomes.

Indexed as

Lung NeoplasmsNeoplasms, Second PrimaryTomography, X-Ray ComputedAgedDiagnosis, DifferentialFemaleHumansMaleMiddle AgedNeoplasm MetastasisRetrospective StudiesCT thoraxLung lesions after cancerLung metastasisSecond primary lung cancerSemantic radiology feature model

Identifiers

PMID42089967
PMCPMC13451270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.